Sector Gamma AS’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
VPM
VCM
AC
Sector Gamma AS's PTCT Position: Q1 2026 in Review
Sector Gamma AS increased its PTC Therapeutics (PTCT) stake by 21% in Q1 2026, buying an estimated $926K and bringing the position to 75,000 shares worth $5.11M. The position accounts for 1.21% of the portfolio, ranked #28.
Sector Gamma AS first reported a position in PTCT in Q1 2019 and has held it in 18 quarters since. The position peaked at $10.3M in Q2 2019. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.
- Sector Gamma AS held 75,000 shares of PTC Therapeutics worth $5.11M as of Q1 2026.
- Sector Gamma AS bought 13,077 PTC Therapeutics shares in Q1 2026, an estimated $926K.
- PTC Therapeutics made up 1.21% of Sector Gamma AS's portfolio in Q1 2026, its #28 holding.
- Sector Gamma AS first reported a position in PTC Therapeutics in Q1 2019 and has held it in 18 quarters since.
- Sector Gamma AS's PTC Therapeutics position peaked at $10.3M in Q2 2019.
- 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.
Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.